BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37422404)

  • 1. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
    Sorvina A; Martini C; Prabhakaran S; Logan JM; S-Y Ung B; Moore C; Johnson IRD; Lazniewska J; Tewari P; Malone V; Brooks RD; Hickey SM; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
    Pathology; 2023 Oct; 55(6):792-799. PubMed ID: 37422404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
    Martini C; Logan JM; Sorvina A; Gordon C; Beck AR; S-Y Ung B; Caruso MC; Moore C; Hocking A; Johnson IRD; Li KL; Karageorgos L; Hopkins AM; Esterman AJ; Huzzell C; Brooks RD; Lazniewska J; Hickey SM; Bader C; Parkinson-Lawrence E; Weigert R; Sorich MJ; Tewari P; Martin C; O'Toole S; Bates M; Ward M; Mohammed B; Keegan H; Watson W; Prendergast S; Heffernan S; NiMhaolcatha S; O'Connor R; Malone V; Carter M; Ryan K; Brady N; Clarke A; Sokol F; Prabhakaran S; Stahl J; Klebe S; Samaratunga H; Delahunt B; Selemidis S; Moretti KL; Butler LM; O'Leary JJ; Brooks DA
    Pathology; 2023 Feb; 55(1):40-51. PubMed ID: 36089417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
    Martini C; Logan JM; Sorvina A; Prabhakaran S; Ung BSY; Johnson IRD; Hickey SM; Brooks RD; ; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
    Virchows Arch; 2023 Sep; ():. PubMed ID: 37704825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal carcinoma of the prostate: a critical re-appraisal.
    Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
    Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
    Varma M
    Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature.
    Grypari IM; Logotheti S; Lazaris AC; Kallidonis P; Fokaefs E; Melachrinou M; Zolota V; Tzelepi V
    Int J Surg Pathol; 2020 Dec; 28(8):918-924. PubMed ID: 32456482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.
    Chen-Maxwell D; Prendeville S
    Histopathology; 2020 Sep; 77(3):503-507. PubMed ID: 32358793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
    Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
    Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head to head: should the intraductal component of invasive prostate cancer be graded?
    Varma M; Epstein JI
    Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
    Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan CC; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
    Pathology; 2020 Feb; 52(2):192-196. PubMed ID: 31843189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria.
    Madan R; Deebajah M; Alanee S; Gupta NS; Carskadon S; Palanisamy N; Williamson SR
    Histopathology; 2019 Jun; 74(7):1081-1087. PubMed ID: 30720899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
    Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
    J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Value of MRI Texture Analysis in Identifying Intraductal Carcinoma of the Prostate Gland].
    Chu L; Si Y; Liu RB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):42-48. PubMed ID: 31950788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
    Logan JM; Hopkins AM; Martini C; Sorvina A; Tewari P; Prabhakaran S; Huzzell C; Johnson IRD; Hickey SM; Ung BS; Lazniewska J; Brooks RD; Moore CR; Caruso MC; Karageorgos L; Martin CM; O'Toole S; Bogue Edgerton L; Ward MP; Bates M; Selemidis S; Esterman A; Heffernan S; Keegan H; Ní Mhaolcatha S; O'Connor R; Malone V; Carter M; Ryan K; Clarke A; Brady N; Klebe S; Samaratunga H; Delahunt B; Sorich MJ; Moretti K; Butler LM; O'Leary JJ; Brooks DA
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter.
    Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
    Am J Surg Pathol; 2021 Nov; 45(11):1527-1533. PubMed ID: 34265803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN expression and morphological patterns in prostatic adenocarcinoma.
    Spieker AJ; Gordetsky JB; Maris AS; Dehan LM; Denney JE; Arnold Egloff SA; Scarpato K; Barocas DA; Giannico GA
    Histopathology; 2021 Dec; 79(6):1061-1071. PubMed ID: 34324714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
    Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
    J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.